Shionogi Co Ltd

General

Total Cases23
Active Cases7
Patents684
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
L3
A
PTAB
L3
A
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
11/19/24
Summons Issued as to Alvogen Pb Research & Development LLC on 11/18/2024; Norwich Pharmaceuticals, Inc. on 11/18/2024. (Attachments: # [1] Summons Issued Norwich Pharma Inc.)(scs) (Entered: 11/19/2024)
11/19/24
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holding Ltd. for Genentech, Inc., Hoffmann-La Roche Inc. filed by Shionogi & Co., Ltd., Hoffmann-La Roche Inc., Genentech, Inc.. (Attachments: # [1] 7.1 Disclosure Statement 2)(scs) (Entered: 11/19/2024)
11/19/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,064,438. (scs) (Entered: 11/19/2024)
11/19/24
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 10/09/2039. (scs) (Entered: 11/19/2024)
11/19/24
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 11/19/2024)
11/19/24
COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Alvogen Pb Research & Development LLC, Norwich Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4551547.) - filed by Hoffmann-La Roche Inc., Shionogi & Co., Ltd., Genentech, Inc.. (Attachments: # [1] Exhibit A, # [2] Civil Cover Sheet)(scs) (Entered: 11/19/2024)
10/24/24
Summons Issued as to Hetero Labs Limited on 10/23/2024; Hetero Labs Limited Unit-III on 10/23/2024; Hetero USA Inc. on 10/23/2024. (Attachments: # [1] Summons Issued, # [2] Summons Issued)(oam) (Entered: 10/24/2024)
10/24/24
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline plc., Corporate Parent Shionogi Limited, Other Affiliate Shionogi & Co., Ltd. for ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (oam) (Entered: 10/24/2024)
10/24/24
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (oam) Modified on 10/24/2024 (oam). (Entered: 10/24/2024)
10/24/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (oam) (Entered: 10/24/2024)